{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["ME/CFS", "clinical trial", "fatigue", "oxygen\u2013ozone therapy", "ozone"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "35011914", "DateRevised": {"Year": "2022", "Month": "01", "Day": "14"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2021", "Month": "12", "Day": "29"}], "ELocationID": ["173", "10.3390/jcm11010173"], "Journal": {"ISSN": "2077-0383", "JournalIssue": {"Volume": "11", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Dec", "Day": "29"}}, "Title": "Journal of clinical medicine", "ISOAbbreviation": "J Clin Med"}, "ArticleTitle": "Male vs. Female Differences in Responding to Oxygen-Ozone Autohemotherapy (O<sub>2</sub>-O<sub>3</sub>-AHT) in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).", "Abstract": {"AbstractText": ["(1) Background: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a syndrome that has fatigue as its major symptom. Evidence suggests that ozone is able to relieve ME/CFS-related fatigue in affected patients. (2) Objective: To evaluate whether differences exist between males and females in ozone therapy outputs in ME/CFS. (3) Methods: In total, 200 patients previously diagnosed with ME/CFS (mean age 33 \u00b1 13 SD years) underwent treatment with oxygen-ozone autohemotherapy (O<sub>2</sub>-O<sub>3</sub>-AHT). Fatigue was investigated via an FSS 7-scoring questionnaire before and following 1 month after treatment. (4) Results: The Mann-Whitney test (MW test) assessed the significance of this difference (H = 13.8041, <i>p</i> = 0.0002), and female patients showed better outcomes than males. This difference was particularly striking in the youngest age cohort (14-29 years), and a KW test resulted in H = 7.1609, <i>p</i> = 0.007 for the \u0394 = 28.3% (males = 3.8, females = 5.3). (5) Conclusions: When treated with O<sub>2</sub>-O<sub>3</sub>-AHT, females respond better than males."]}, "AuthorList": [{"Identifier": ["0000-0003-1789-8307"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy."}], "LastName": "Chirumbolo", "ForeName": "Salvatore", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Italian Society of Oxygen Ozone Therapy (SIOOT), University of Pavia, 27100 Pavia, Italy."}], "LastName": "Valdenassi", "ForeName": "Luigi", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Italian Society of Oxygen Ozone Therapy (SIOOT), University of Pavia, 27100 Pavia, Italy."}], "LastName": "Franzini", "ForeName": "Marianno", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Italian Society of Oxygen Ozone Therapy (SIOOT), University of Pavia, 27100 Pavia, Italy."}, {"Identifier": [], "Affiliation": "Villa Mafalda Clinics, Via Monte delle Gioie 5 Rome, 00199 Roma, Italy."}], "LastName": "Pandolfi", "ForeName": "Sergio", "Initials": "S"}, {"Identifier": ["0000-0003-3422-2747"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Italian Society of Oxygen Ozone Therapy (SIOOT), University of Pavia, 27100 Pavia, Italy."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Department of Drug Sciences, University of Pavia, 27100 Pavia, Italy."}], "LastName": "Ricevuti", "ForeName": "Giovanni", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Tirelli Medical Group, 33170 Pordenone, Italy."}], "LastName": "Tirelli", "ForeName": "Umberto", "Initials": "U"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "J Clin Med", "NlmUniqueID": "101606588", "ISSNLinking": "2077-0383"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Deumer U.S., Varesi A., Floris V., Savioli G., Mantovani E., L\u00f3pez-Carrasco P., Rosati G.M., Prasad S., Ricevuti G. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview. J. Clin. Med. 2021;10:4786. doi: 10.3390/jcm10204786.", "ArticleIdList": ["10.3390/jcm10204786", "PMC8538807", "34682909"]}, {"Citation": "Barhorst E.E., Boruch A.E., Cook D.B., Lindheimer J.B. Pain-related post-exertional malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia: A systematic review and three-level meta-analysis. Pain Med. 2021:pnab308. doi: 10.1093/pm/pnab308.", "ArticleIdList": ["10.1093/pm/pnab308", "34668532"]}, {"Citation": "Noor N., Urits I., Degueure A., Rando L., Kata V., Cornett E.M., Kaye A.D., Imani F., Narimani-Zamanabadi M., Varrassi G., et al. A Comprehensive Update of the Current Understanding of Chronic Fatigue Syndrome. Anesth. Pain Med. 2021;11:e113629. doi: 10.5812/aapm.113629.", "ArticleIdList": ["10.5812/aapm.113629", "PMC8438707", "34540633"]}, {"Citation": "Lim E.J., Son C.G. Prevalence of Chronic Fatigue Syndrome (CFS) in Korea and Japan: A Meta-Analysis. J. Clin. Med. 2021;10:3204. doi: 10.3390/jcm10153204.", "ArticleIdList": ["10.3390/jcm10153204", "PMC8347596", "34361987"]}, {"Citation": "Tirelli U., Lleshi A., Berretta M., Spina M., Talamini R., Giacalone A. Treatment of 741 Italian patients with chronic fatigue syndrome. Eur. Rev. Med. Pharmacol. Sci. 2013;17:2847\u20132852.", "ArticleIdList": ["24254550"]}, {"Citation": "Tirelli U., Cirrito C., Pavanello M., Del Pup L., Lleshi A., Berretta M. Oxygen-ozone therapy as support and palliative therapy in 50 cancer patients with fatigue\u2014A short report. Eur. Rev. Med. Pharmacol. Sci. 2018;22:8030\u20138033.", "ArticleIdList": ["30536352"]}, {"Citation": "Arpino C., Carrieri M.P., Valesini G., Pizzigallo E., Rovere P., Tirelli U., Conti F., Dialmi P., Barberio A., Rusconi N., et al. Idiopathic chronic fatigue and chronic fatigue syndrome: A comparison of two case-definitions. Ann. Ist. Super. Sanita. 1999;35:435\u2013441.", "ArticleIdList": ["10721210"]}, {"Citation": "Tirelli U., Chierichetti F., Tavio M., Simonelli C., Bianchin G., Zanco P., Ferlin G. Brain positron emission tomography (PET) in chronic fatigue syndrome: Preliminary data. Am. J. Med. 1998;105:54S\u201358S. doi: 10.1016/S0002-9343(98)00179-X.", "ArticleIdList": ["10.1016/S0002-9343(98)00179-X", "9790483"]}, {"Citation": "Montoya J.G., Holmes T.H., Anderson J.N., Maecker H.T., Rosenberg-Hasson Y., Valencia I.J., Chu L., Younger J.W., Tato C.M., Davis M.M. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc. Natl. Acad. Sci. USA. 2017;114:E7150\u2013E7158. doi: 10.1073/pnas.1710519114.", "ArticleIdList": ["10.1073/pnas.1710519114", "PMC5576836", "28760971"]}, {"Citation": "Tirelli U., Marotta G., Improta S., Pinto A. Immunological abnormalities in patients with chronic fatigue syndrome. Scand. J. Immunol. 1994;40:601\u2013608. doi: 10.1111/j.1365-3083.1994.tb03511.x.", "ArticleIdList": ["10.1111/j.1365-3083.1994.tb03511.x", "7997849"]}, {"Citation": "Tirelli V., Pinto A., Marotta G., Crovato M., Quaia M., De Paoli P., Galligioni E., Santini G. Clinical and immunologic study of 205 patients with chronic fatigue syndrome: A case series from Italy. Arch. Intern. Med. 1993;153:116\u2013120. doi: 10.1001/archinte.1993.00410010136014.", "ArticleIdList": ["10.1001/archinte.1993.00410010136014", "8422193"]}, {"Citation": "Est\u00e9vez-L\u00f3pez F., Mudie K., Wang-Steverding X., Bakken I.J., Ivanovs A., Castro-Marrero J., Nacul L., Alegre J., Zalewski P., S\u0142omko J., et al. Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology. J. Clin. Med. 2020;9:1557. doi: 10.3390/jcm9051557.", "ArticleIdList": ["10.3390/jcm9051557", "PMC7290765", "32455633"]}, {"Citation": "Vincent A., Brimmer D.J., Whipple M.O., Jones J.F., Boneva R., Lahr B.D., Maloney E., St Sauver J.L., Reeves W.C. Prevalence, incidence, and classification of chronic fatigue syndrome in Olmsted County, Minnesota, as estimated using the Rochester Epidemiology Project. Mayo Clin. Proc. 2012;87:1145\u20131152. doi: 10.1016/j.mayocp.2012.08.015.", "ArticleIdList": ["10.1016/j.mayocp.2012.08.015", "PMC3518652", "23140977"]}, {"Citation": "Lim E.J., Ahn Y.C., Jang E.S., Lee S.W., Lee S.H., Son C.G. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) J. Transl. Med. 2020;18:100. doi: 10.1186/s12967-020-02269-0.", "ArticleIdList": ["10.1186/s12967-020-02269-0", "PMC7038594", "32093722"]}, {"Citation": "Capelli E., Lorusso L., Ghitti M., Venturini L., Cusa C., Ricevuti G. Chronic fatigue syndrome: Features of a population of patients from northern Italy. Int. J. Immunopathol. Pharmacol. 2015;28:53\u201359. doi: 10.1177/0394632015572074.", "ArticleIdList": ["10.1177/0394632015572074", "25816406"]}, {"Citation": "Spazzapan S., Bearz A., Tirelli U. Fatigue in cancer patients receiving chemotherapy. An analysis of published studies. Ann. Oncol. 2004;15:1576.", "ArticleIdList": ["15367422"]}, {"Citation": "Solomon L., Reeves W.C. Factors influencing the diagnosis of chronic fatigue syndrome. Arch. Intern. Med. 2004;164:2241\u20132245. doi: 10.1001/archinte.164.20.2241.", "ArticleIdList": ["10.1001/archinte.164.20.2241", "15534161"]}, {"Citation": "Brenna E., Araja D., Pheby D.F.H. Comparative Survey of People with ME/CFS in Italy, Latvia, and the UK: A Report on Behalf of the Socioeconomics Working Group of the European ME/CFS Research Network (EUROMENE) Medicina. 2021;57:300. doi: 10.3390/medicina57030300.", "ArticleIdList": ["10.3390/medicina57030300", "PMC8005199", "33806902"]}, {"Citation": "Kennedy G., Abbot N.C., Spence V., Underwood C., Belch J.J. The specificity of the CDC-1994 criteria for chronic fatigue syndrome: Comparison of health status in three groups of patients who fulfill the criteria. Ann. Epidemiol. 2004;14:95\u2013100. doi: 10.1016/j.annepidem.2003.10.004.", "ArticleIdList": ["10.1016/j.annepidem.2003.10.004", "15018881"]}, {"Citation": "Kuratsune H. Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Brain Nerve. 2018;70:11\u201318.", "ArticleIdList": ["29348370"]}, {"Citation": "Carruthers B.M., van de Sande M.I., De Meirleir K.L., Klimas N.G., Broderick G., Mitchell T., Staines D., Powles A.C., Speight N., Vallings R., et al. Myalgic encephalomyelitis: International Consensus Criteria. J. Intern. Med. 2011;270:327\u2013338. doi: 10.1111/j.1365-2796.2011.02428.x.", "ArticleIdList": ["10.1111/j.1365-2796.2011.02428.x", "PMC3427890", "21777306"]}, {"Citation": "Bruun Wyller V., Bj\u00f8rneklett A., Brubakk O., Festv\u00e5g L., Follestad I., Malt U., Malterud K., Nyland H., Ramb\u00f8l H., Stubhaug B., et al. Diagnosis and Treatment of Chronic Fatigue Syndrome/Myalgic Encephalopathy (CFS/ME) Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); Oslo, Norway: 2006. Report from Norwegian Knowledge Centre for the Health Services (NOKC) No. 09-2006.", "ArticleIdList": ["29320016"]}, {"Citation": "Chew-Graham C., Dowrick C., Wearden A., Richardson V., Peters S. Making the diagnosis of Chronic Fatigue Syndrome/Myalgic Encephalitis in primary care: A qualitative study. BMC Fam. Pract. 2010;11:16. doi: 10.1186/1471-2296-11-16.", "ArticleIdList": ["10.1186/1471-2296-11-16", "PMC2836312", "20178588"]}, {"Citation": "Son C.G. Differential diagnosis between \u201cchronic fatigue\u201d and \u201cchronic fatigue syndrome\u201d. Integr. Med. Res. 2019;8:89\u201391. doi: 10.1016/j.imr.2019.04.005.", "ArticleIdList": ["10.1016/j.imr.2019.04.005", "PMC6522773", "31193269"]}, {"Citation": "Nelsen D.A., Jr. Differential diagnosis for chronic fatigue syndrome. Am. Fam. Physician. 2003;67:252. author reply 252.", "ArticleIdList": ["12562147"]}, {"Citation": "Craig T., Kakumanu S. Chronic fatigue syndrome: Evaluation and treatment. Am. Fam. Physician. 2002;65:1083\u20131089.", "ArticleIdList": ["11925084"]}, {"Citation": "Tirelli U., Cirrito C., Pavanello M. Ozone therapy is an effective therapy in chronic fatigue syndrome: Result of an Italian study in 65 patients. Ozon Ther. 2018;3:27\u201330. doi: 10.4081/ozone.2018.7812.", "ArticleIdList": ["10.4081/ozone.2018.7812"]}, {"Citation": "Morelli L., Bramani S.C., Morelli F.C. Oxygen-ozone therapy in meningoencephalitis and chronic fatigue syndrome. Treatment in the field of competitive sports: Case report. Ozone Ther. 2019;4:20\u201323. doi: 10.4081/ozone.2019.8176.", "ArticleIdList": ["10.4081/ozone.2019.8176"]}, {"Citation": "Borrelli E., Bocci V. A novel therapeutic option for Chronic Fatigue Syndrome and Fibromyalgia. Rivista Ital. Ossig-Ozonoterap. 2002;1:149\u2013153."}, {"Citation": "Viebahn-Haensler R., Le\u00f3n Fern\u00e1ndez O.S. Ozone in Medicine. The Low-Dose Ozone Concept and Its Basic Biochemical Mechanisms of Action in Chronic Inflammatory Diseases. Int. J. Mol. Sci. 2021;22:7890. doi: 10.3390/ijms22157890.", "ArticleIdList": ["10.3390/ijms22157890", "PMC8346137", "34360655"]}, {"Citation": "Bj\u00f8rklund G., Dadar M., Pivina L., Do\u015fa M.D., Semenova Y., Maes M. Environmental, Neuro-immune, and Neuro-oxidative Stress Interactions in Chronic Fatigue Syndrome. Mol. Neurobiol. 2020;57:4598\u20134607. doi: 10.1007/s12035-020-01939-w.", "ArticleIdList": ["10.1007/s12035-020-01939-w", "32761353"]}, {"Citation": "Chirumbolo S., Valdenassi L., Simonetti V., Bertossi D., Ricevuti G., Franzini M., Pandolfi S. Insights on the mechanisms of action of ozone in the medical therapy against COVID-19. Int. Immunopharmacol. 2021;96:107777. doi: 10.1016/j.intimp.2021.107777.", "ArticleIdList": ["10.1016/j.intimp.2021.107777", "PMC8112288", "34020394"]}, {"Citation": "Paul B.D., Lemle M.D., Komaroff A.L., Snyder S.H. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl. Acad. Sci. USA. 2021;118:e2024358118. doi: 10.1073/pnas.2024358118.", "ArticleIdList": ["10.1073/pnas.2024358118", "PMC8403932", "34400495"]}, {"Citation": "Baker R., Shaw E.J. Diagnosis and management of chronic fatigue syndrome or myalgic encephalomyelitis (or encephalopathy): Summary of NICE guidance. BMJ. 2007;335:446\u2013448. doi: 10.1136/bmj.39302.509005.AE.", "ArticleIdList": ["10.1136/bmj.39302.509005.AE", "PMC1962830", "17762037"]}, {"Citation": "Neuberger G.B. Measures of fatigue Arthritis and Rheumatisms. Arthr. Care Res. 2003;48:S175\u2013S183. doi: 10.1002/art.11405.", "ArticleIdList": ["10.1002/art.11405"]}, {"Citation": "Tirelli U., Franzini M., Valdenassi L., Pisconti S., Taibi R., Torrisi C., Pandolfi S., Chirumbolo S. Fatigue in post-acute sequelae of SARS-CoV2 (PASC) treated with oxygen-ozone autohemotherapy-Preliminary results on 100 patients. Eur. Rev. Med. Pharmacol. Sci. 2021;25:5871\u20135875.", "ArticleIdList": ["34604980"]}, {"Citation": "Lvis A.M., Ekta J.S. Ozone therapy: A clinical review. J. Nat. Sci. Biol. Med. 2011;2:66\u201370.", "ArticleIdList": ["PMC3312702", "22470237"]}, {"Citation": "Anderson G., Maes M. Mitochondria and immunity in chronic fatigue syndrome. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2020;103:109976. doi: 10.1016/j.pnpbp.2020.109976.", "ArticleIdList": ["10.1016/j.pnpbp.2020.109976", "32470498"]}, {"Citation": "Maes M., Twisk F.N., Kubera M., Ringel K. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Increased interleukin-1, tumor necrosis factor-\u03b1, PMN-elastase, lysozyme and neopterin. J. Affect. Disord. 2012;136:933\u2013939. doi: 10.1016/j.jad.2011.09.004.", "ArticleIdList": ["10.1016/j.jad.2011.09.004", "21975140"]}, {"Citation": "Maes M., Twisk F.N., Ringel K. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: Inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Psychother. Psychosom. 2012;81:286\u2013295. doi: 10.1159/000336803.", "ArticleIdList": ["10.1159/000336803", "22832503"]}, {"Citation": "Brenu E.W., Huth T.K., Hardcastle S.L., Fuller K., Kaur M., Johnston S., Ramos S.B., Staines D.R., Marshall-Gradisnik S.M. Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis. Int. Immunol. 2014;26:233\u2013242. doi: 10.1093/intimm/dxt068.", "ArticleIdList": ["10.1093/intimm/dxt068", "24343819"]}, {"Citation": "Wei M., Tu L., Liang Y.H., Liu J., Gong Y.J., Zhang J.H., Zhang Y.H. Effects of ozone exposure on percentage of CD4(+)CD25(high)Foxp(3+) regulatory T cells and mRNA expression of Foxp3 in asthmatic rats. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2013;31:693\u2013696.", "ArticleIdList": ["24064130"]}, {"Citation": "Broderick G., Fuite J., Kreitz A., Vernon S.D., Klimas N., Fletcher M.A. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav. Immun. 2010;24:1209\u20131217. doi: 10.1016/j.bbi.2010.04.012.", "ArticleIdList": ["10.1016/j.bbi.2010.04.012", "PMC2939140", "20447453"]}, {"Citation": "Izadi M., Tahmasebi S., Pustokhina I., Yumashev A.V., Lakzaei T., Alvanegh A.G., Roshangar L., Dadashpour M., Yousefi M., Ahmadi M. Changes in Th17 cells frequency and function after ozone therapy used to treat multiple sclerosis patients. Mult. Scler. Relat. Disord. 2020;46:102466. doi: 10.1016/j.msard.2020.102466.", "ArticleIdList": ["10.1016/j.msard.2020.102466", "32862036"]}, {"Citation": "Chen Z.H., Saito Y., Yoshida Y., Sekine A., Noguchi N., Niki E. 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J. Biol. Chem. 2005;280:41921\u201341927. doi: 10.1074/jbc.M508556200.", "ArticleIdList": ["10.1074/jbc.M508556200", "16219762"]}, {"Citation": "Wang X., Dong H., Li Q., Li Y., Hong A. Thioredoxin induces Tregs to generate an immunotolerant tumor microenvironment in metastatic melanoma. Oncoimmunology. 2015;4:e1027471. doi: 10.1080/2162402X.2015.1027471.", "ArticleIdList": ["10.1080/2162402X.2015.1027471", "PMC4570104", "26405597"]}, {"Citation": "Meeus M., Van Eupen I., Hondequin J., De Hauwere L., Kos D., Nijs J. Nitric oxide concentrations are normal and unrelated to activity level in chronic fatigue syndrome: A case-control study. In Vivo. 2010;24:865\u2013869.", "ArticleIdList": ["21164046"]}, {"Citation": "Robinson M., Gray S.R., Watson M.S., Kennedy G., Hill A., Belch J.J., Nimmo M.A. Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome. Scand. J. Med. Sci. Sports. 2010;20:282\u2013290. doi: 10.1111/j.1600-0838.2009.00895.x.", "ArticleIdList": ["10.1111/j.1600-0838.2009.00895.x", "19422646"]}, {"Citation": "Milne G.L., Musiek E.S., Morrow J.D. F2-isoprostanes as markers of oxidative stress in vivo: An overview. Biomarkers. 2005;10((Suppl. S1)):S10\u2013S23. doi: 10.1080/13547500500216546.", "ArticleIdList": ["10.1080/13547500500216546", "16298907"]}, {"Citation": "Goodman W.A., Bedoyan S.M., Havran H.L., Richardson B., Cameron M.J., Pizarro T.T. Impaired estrogen signaling underlies regulatory T cell loss-of-function in the chronically inflamed intestine. Proc. Natl. Acad. Sci. USA. 2020;117:17166\u201317176. doi: 10.1073/pnas.2002266117.", "ArticleIdList": ["10.1073/pnas.2002266117", "PMC7382259", "32632016"]}, {"Citation": "Gr\u00e4ns H., Nilsson M., Dahlman-Wright K., Eveng\u00e5rd B. Reduced levels of oestrogen receptor beta mRNA in Swedish patients with chronic fatigue syndrome. J. Clin. Pathol. 2007;60:195\u2013198. doi: 10.1136/jcp.2005.035956.", "ArticleIdList": ["10.1136/jcp.2005.035956", "PMC1860629", "16731592"]}, {"Citation": "Ishii T., Warabi E. Mechanism of Rapid Nuclear Factor-E2-Related Factor 2 (Nrf2) Activation via Membrane-Associated Estrogen Receptors: Roles of NADPH Oxidase 1, Neutral Sphingomyelinase 2 and Epidermal Growth Factor Receptor (EGFR) Antioxidants. 2019;8:69. doi: 10.3390/antiox8030069.", "ArticleIdList": ["10.3390/antiox8030069", "PMC6466580", "30889865"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "23"}, {"Year": "2021", "Month": "12", "Day": "23"}, {"Year": "2021", "Month": "12", "Day": "27"}, {"Year": "2022", "Month": "1", "Day": "11", "Hour": "1", "Minute": "16"}, {"Year": "2022", "Month": "1", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "12", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "12", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["35011914", "PMC8745436", "10.3390/jcm11010173", "jcm11010173"]}}], "PubmedBookArticle": []}